Marketing-authorisation holder · United States
Rising
52 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 52
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAMINOPHEN1gm/vial · Powder | Paracetamol | United States | Not marketed | 2021 |
| ACETYLCYSTEINE6gm/30ml (200mg/ml) · Injectable | Acetylcysteine | United States | Marketed | 2012 |
| ADENOSINE60mg/20ml (3mg/ml) | 90mg/30ml (3mg/ml) · Solution | Adenosine | United States | Marketed | 2013 |
| AKPENTOLATE1% | 2% · Solution/drops | Cyclopentolate | United States | Marketed | 1997 |
| ALBUTEROL SULFATE4mg base | 8mg base · Tablet, extended release | Salbutamol | United States | Not marketed | 2007 |
| ALFENTA0.5mg base/ml · Injectable | Alfentanil | United States | Marketed | 1986 |
| AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE10mg base; 20mg | 10mg base; 40mg | 2.5mg base; 10mg | 5mg base; 10mg | 5mg base; 20mg | 5mg base; 40mg · Capsule | Amlodipine, Benazepril | United States | Marketed | 2007 |
| APRACLONIDINE HYDROCHLORIDE0.5% base · Solution/drops | Apraclonidine | United States | Marketed | 2009 |
| ASTELIN0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Spray, metered | Azelastine | United States | Not marketed | 1996 |
| AVITA0.025% · GEL | Tretinoin | United States | Not marketed | 1998 |
| AZATHIOPRINE100mg | 25mg | 50mg | 75mg · Tablet | Azathioprine | United States | Marketed | 1996 |
| BENAZEPRIL HYDROCHLORIDE10mg | 20mg | 40mg | 5mg · Tablet | Benazepril | United States | Marketed | 2004 |
| CARBIDOPA AND LEVODOPA10mg; 100mg | 25mg; 100mg | 25mg; 250mg · Tablet, orally disintegrating | Carbidopa, Levodopa | United States | Marketed | 2008 |
| CROMOLYN SODIUM100mg/5ml · Concentrate | Cromolyn | United States | Marketed | 2009 |
| DICHLORPHENAMIDE50mg · Tablet | Dichlorphenamide | United States | Marketed | 2025 |
| DICLOFENAC SODIUM37.5mg/ml (37.5mg/ml) · Solution | Diclofenac | United States | Not marketed | 2019 |
| DIFLORASONE DIACETATE0.05% · Ointment | Diflorasone | United States | Marketed | 1999 |
| DILTIAZEM HYDROCHLORIDE100mg/vial | 125mg/25ml | 50mg/10ml | 5mg/ml · Injectable | Diltiazem | United States | Marketed | 1996 |
| DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Chlorothiazide | United States | Not marketed | 1958 |
| DIURIL500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Chlorothiazide | United States | Not marketed | 1958 |
| DIVALPROEX SODIUM125mg valproic acid · Capsule, delayed rel pellets | Divalproex | United States | Marketed | 2009 |
| ESCITALOPRAM OXALATE10mg base | 20mg base | 5mg base · Capsule | Escitalopram | United States | Not marketed | 2007 |
| EXTINA2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Aerosol, foam | Ketoconazole | United States | Not marketed | 2007 |
| FLUOCINOLONE ACETONIDE0.01% · OIL | Fluocinolone acetonide | United States | Marketed | 2011 |
| IMIPRAMINE PAMOATE100mg hydrochloride | 125mg hydrochloride | 150mg hydrochloride | 75mg hydrochloride · Capsule | Imipramine | United States | Marketed | 2010 |